Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Benjamin G Neel

Showing results (201-210 of 223) with videos related to

Pageof 23
Sort By:
Molecular & Cellular Proteomics : MCP|June 21, 2023
Proteomic Dynamics of Breast Cancer Cell Lines Identifies Potential Therapeutic Protein TargetsRui Sun, Weigang Ge, Yi Zhu, et al.
The Journal of Experimental Medicine|October 12, 2020
SHP2 inhibition diminishes KRASG12C cycling and promotes tumor microenvironment remodelingCarmine Fedele, Shuai Li, Kai Wen Teng, et al.
Genes, Chromosomes & Cancer|December 8, 2007
SOS1 mutations are rare in human malignancies: implications for Noonan Syndrome patientsKenneth D Swanson, Jordan M Winter, Marcelo Reis, et al.
Cancer Research|December 18, 2004
Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemiaMohamed Bentires-Alj, J Guillermo Paez, Frank S David, et al.
Cancer Discovery|November 7, 2020
Genetically Defined Syngeneic Mouse Models of Ovarian Cancer as Tools for the Discovery of Combination ImmunotherapySonia Iyer, Shuang Zhang, Simge Yucel, et al.
Cancer Discovery|December 16, 2021
Ontogeny and Vulnerabilities of Drug-Tolerant Persisters in HER2+ Breast CancerChewei Anderson Chang, Jayu Jen, Shaowen Jiang, et al.
Cell|August 22, 2017
Restoration of TET2 Function Blocks Aberrant Self-Renewal and Leukemia ProgressionLuisa Cimmino, Igor Dolgalev, Yubao Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2015
Clinical Utility of Patient-Derived Xenografts to Determine Biomarkers of Prognosis and Map Resistance Pathways in EGFR-Mutant Lung AdenocarcinomaErin L Stewart, Celine Mascaux, Nhu-An Pham, et al.
Cancer Research|September 20, 2023
Genome-Wide CRISPR Screens Identify Multiple Synthetic Lethal Targets That Enhance KRASG12C Inhibitor EfficacySuman Mukhopadhyay, Hsin-Yi Huang, Ziyan Lin, et al.
Nature Cell Biology|June 21, 2016
PTP1B controls non-mitochondrial oxygen consumption by regulating RNF213 to promote tumour survival during hypoxiaRobert S Banh, Caterina Iorio, Richard Marcotte, et al.
Pageof 23

Showing results (201-210 of 223) with videos related to

Sort By:
Pageof 23
Molecular & Cellular Proteomics : MCP|June 21, 2023
Proteomic Dynamics of Breast Cancer Cell Lines Identifies Potential Therapeutic Protein TargetsRui Sun, Weigang Ge, Yi Zhu, et al.
The Journal of Experimental Medicine|October 12, 2020
SHP2 inhibition diminishes KRASG12C cycling and promotes tumor microenvironment remodelingCarmine Fedele, Shuai Li, Kai Wen Teng, et al.
Genes, Chromosomes & Cancer|December 8, 2007
SOS1 mutations are rare in human malignancies: implications for Noonan Syndrome patientsKenneth D Swanson, Jordan M Winter, Marcelo Reis, et al.
Cancer Research|December 18, 2004
Activating mutations of the noonan syndrome-associated SHP2/PTPN11 gene in human solid tumors and adult acute myelogenous leukemiaMohamed Bentires-Alj, J Guillermo Paez, Frank S David, et al.
Cancer Discovery|November 7, 2020
Genetically Defined Syngeneic Mouse Models of Ovarian Cancer as Tools for the Discovery of Combination ImmunotherapySonia Iyer, Shuang Zhang, Simge Yucel, et al.
Cancer Discovery|December 16, 2021
Ontogeny and Vulnerabilities of Drug-Tolerant Persisters in HER2+ Breast CancerChewei Anderson Chang, Jayu Jen, Shaowen Jiang, et al.
Cell|August 22, 2017
Restoration of TET2 Function Blocks Aberrant Self-Renewal and Leukemia ProgressionLuisa Cimmino, Igor Dolgalev, Yubao Wang, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2015
Clinical Utility of Patient-Derived Xenografts to Determine Biomarkers of Prognosis and Map Resistance Pathways in EGFR-Mutant Lung AdenocarcinomaErin L Stewart, Celine Mascaux, Nhu-An Pham, et al.
Cancer Research|September 20, 2023
Genome-Wide CRISPR Screens Identify Multiple Synthetic Lethal Targets That Enhance KRASG12C Inhibitor EfficacySuman Mukhopadhyay, Hsin-Yi Huang, Ziyan Lin, et al.
Nature Cell Biology|June 21, 2016
PTP1B controls non-mitochondrial oxygen consumption by regulating RNF213 to promote tumour survival during hypoxiaRobert S Banh, Caterina Iorio, Richard Marcotte, et al.
Pageof 23